389 related articles for article (PubMed ID: 31093272)
1. Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.
Yu CC; Jiang T; Yang AF; Du YJ; Wu M; Kong LH
Neural Plast; 2019; 2019():6856327. PubMed ID: 31093272
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
[TBL] [Abstract][Full Text] [Related]
3. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
De Plano LM; Saitta A; Oddo S; Caccamo A
Cells; 2024 Apr; 13(8):. PubMed ID: 38667333
[TBL] [Abstract][Full Text] [Related]
5. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
[TBL] [Abstract][Full Text] [Related]
7. Neuroepigenetics and Alzheimer's Disease: An Update.
Zusso M; Barbierato M; Facci L; Skaper SD; Giusti P
J Alzheimers Dis; 2018; 64(3):671-688. PubMed ID: 29991138
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
9. Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's disease.
Wei X; Du P; Zhao Z
Neurosci Lett; 2021 Oct; 763():136196. PubMed ID: 34437990
[TBL] [Abstract][Full Text] [Related]
10. Histone Modifications in Alzheimer's Disease.
Santana DA; Smith MAC; Chen ES
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833274
[TBL] [Abstract][Full Text] [Related]
11. Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease.
Gil L; Niño SA; Guerrero C; Jiménez-Capdeville ME
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638632
[TBL] [Abstract][Full Text] [Related]
12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
13. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
14. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulons in Alzheimer's disease.
Raval M; Mishra S; Tiwari AK
Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
[TBL] [Abstract][Full Text] [Related]
16. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
[TBL] [Abstract][Full Text] [Related]
17. Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.
Song Y; Zhu XY; Zhang XM; Xiong H
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077101
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.
Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M; Volpe M; Rubattu S
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31941075
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications of tau protein in Alzheimer's disease.
Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
[TBL] [Abstract][Full Text] [Related]
20. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
